Cita APA

Varey, A. H. R., Rennel, E. S., Qiu, Y., Bevan, H. S., Perrin, R. M., Raffy, S., . . . Bates, D. O. (2008). VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: Balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Nature Publishing Group.

Citación estilo Chicago

Varey, A H R., et al. VEGF(165)b, an Antiangiogenic VEGF-A Isoform, Binds and Inhibits Bevacizumab Treatment in Experimental Colorectal Carcinoma: Balance of Pro- and Antiangiogenic VEGF-A Isoforms Has Implications for Therapy. Nature Publishing Group, 2008.

Cita MLA

Varey, A H R., et al. VEGF(165)b, an Antiangiogenic VEGF-A Isoform, Binds and Inhibits Bevacizumab Treatment in Experimental Colorectal Carcinoma: Balance of Pro- and Antiangiogenic VEGF-A Isoforms Has Implications for Therapy. Nature Publishing Group, 2008.